Sight Sciences, Inc. SGHT Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Revenue by Business | |||||
| Dry Eye | $1.64M-58.6% | $3.96M-41.3% | $6.75M+36.3% | $4.95M+101% | |
| Surgical Glaucoma | $75.72M-0.2% | $75.9M+2.1% | $74.31M+13.3% | $65.59M+41.1% | |
| Gross Profit by Business | |||||
| Dry Eye | $972K-46.9% | $1.83M-50.4% | $3.69M+50.3% | $2.46M+661% | |
| Surgical Glaucoma | $65.69M-1.1% | $66.45M+1.5% | $65.48M+14.3% | $57.3M+43.2% | |
| Cost of Goods Sold by Business | |||||
| Dry Eye | $667K-68.7% | $2.13M-30.1% | $3.05M-25.0% | $4.07M+90.3% | |
| Surgical Glaucoma | $10.03M+6.1% | $9.45M+7.0% | $8.83M+6.4% | $8.3M+28.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Sight Sciences, Inc. break its business down?
- Sight Sciences, Inc. (SGHT) reports revenue by business across 2 parts — Dry Eye and Surgical Glaucoma. Each is extracted from the segment footnotes and tracked over time.
- Where does Sight Sciences, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Sight Sciences, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
